European Companies Search Engine
EU funding (€222,728): Mechanisms of cell plasticity in the liver Hor28 Jul 2022 EU Research and Innovation programme "Horizon"
Overview
Text
Mechanisms of cell plasticity in the liver
The liver can regenerate thanks to a unique cell plasticity in which “terminally differentiated cells” change identity. Hepatocytes, the most abundant cell type sustaining liver metabolism, can transdifferentiate into a completely different cell type to repair the bile duct epithelium, which entails not only a fate switch but also a conversion of epithelial polarity. Despite this regenerative capacity, bile duct diseases present a major clinical challenge, often requiring a liver transplant. Activating and controlling endogenous regenerative programs, which preliminary data suggest are liver region-specific, is thus a promising therapeutic strategy but requires a deeper understanding of the underlying mechanisms. Based on regional differences in the quality of regenerated bile ducts in a mouse model of Alagille syndrome, I hypothesize that bile ducts in the hilar region regenerate via cholangiocyte proliferation, yielding well-formed epithelia, while bile ducts at the organ periphery develop de novo via hepatocyte transdifferentiation, yielding malformed bile ducts with aberrant polarity. Because there are multiple cell sources for liver repair, PlasticLiver aims to account for spatial and within-cell type heterogeneity in the liver during bile duct regeneration. Taking advantage of a novel cutting-edge approach for high resolution barcode lineage tracing and gene expression profiling co-developed in my host lab, I will resolve region-specific cell sources and mechanisms in developing and regenerating livers of a mouse model of Alagille syndrome. Moreover, combining generated single cell gene expression data and microscopy analysis of healthy and regenerated tissues, I will identify molecular mechanisms and potential targets to improve epithelial polarity in regenerated peripheral bile ducts. Ultimately, PlasticLiver will yield fundamental mechanistic insights into cell fate decisions and why liver, but no other organs, uses this type of cellular plasticity.
Funded Companies:
| Company name | Funding amount |
| Karolinska Institutet | €222,728 |
Source: https://cordis.europa.eu/project/id/101057846
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Karolinska Institutet STATLIG MYNDIGHET, Stockholm, Sweden.